⌘K

Login Start Free

Home/Filings/4/0001213900-22-013590

4//SEC Filing

Johns Stefanie 4

Accession 0001213900-22-013590

CIK 0001711786other

View on SEC.gov Company Profile

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:15 PM ET

Size

5.3 KB

Accession

0001213900-22-013590

Insider Transaction Report

Form 4

Period: 2022-03-16

Hoth Therapeutics, Inc.HOTH

Chief Scientific Officer

Transactions

Award
Options
2022-03-16+250,000→ 250,000 total
Exercise: $0.59From: 2022-03-16Exp: 2032-03-16→ Common Stock (250,000 underlying)

Footnotes (1)

[F1]The options were used pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Hoth Therapeutics, Inc.

CIK 0001711786

Entity typeother

Related Parties

1

filerCIK 0001823147

Filing Metadata

Form type: 4
Filed: Mar 17, 8:00 PM ET
Accepted: Mar 18, 4:15 PM ET
Size: 5.3 KB

View on SEC.gov